MedRide granted temporary resumption of medical transport
The TRO became effective on Feb. 20 and allows MedRide to resume NEMT services for a 14-day period until March 6.
MedRide shared a statement on its website, 'We are truly relieved to announce that a state court judge has granted MedRide the ability to resume service for all Health First Colorado patients, starting on February 21.'
Andy Boian for MedRide said the company is confident it will continue service past March 6, filing with the court to continue past the 14-day deadline or get an extension of the TRO.
Colorado Department of Health Care Policy & Financing (HCPF) is advising anyone who needs NEMT services after March 6 to be aware the TRO does not authorize MedRide to provide services after that date. If you need NEMT services after March 6, HCPF has a list of all NEMT providers on its website.
Those in need of services can contact (800) 221-3943 to get help finding a NEMT provider in their area as well.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
World's deadliest animal is probably outside your Florida home right now. Protection tips
What's the world's most dangerous animal? Hint: It's plentiful in Florida and no, it's not an alligator, shark or python. According to the Centers for Disease Control the deadliest animal in the world is the mosquito. "The mosquito kills more people than any other creature in the world," the CDC said, noting the flying nuisance spreads such diseases as malaria, dengue, West Nile, yellow fever, Zika and chikungunya. The Florida Department of Health said there are 80 types of mosquitoes in the state, many of which transmit diseases. The agency tracks mosquito-borne illnesses — known as arboviruses — acquired locally and those contracted by people with a history of travel. Here's what you should know, including how you can protect yourself and your family. Mosquito-borne illnesses confirmed in Florida so far this year The latest report from the Florida Department of Health has confirmed the following cases of mosquito-borne illnesses in the state between Jan. 1 through Aug. 2: West Nile Virus: 5 asymptomatic blood donors Escambia: 5 Chikungunya: 4 cases in those with travel history Broward: 2 Lake: 1 Miami-Dade: 1 Dengue: 122 cases in those with travel history; 7 cases in non-Florida residents Bay: 1 Brevard: 2 Broward: 10 Clay: 1 Collier: 2 Duval: 3 Escambia: 1 Hillsborough: 6 Lake: 3 Lee: 4 Manatee: 1 Marion: 1 Miami-Dade: 63 Okeechobee: 3 Orange: 6 Osceola: 2 Palm Beach; 5 Pasco: 1 Pinellas: 3 Polk: 1 St. Johns: 1 St. Lucie: 1 Volusia: 1 Denque acquired in Florida: 8 cases Brevard: 6 Miami-Dade: 2 Malaria: 28 cases in those with travel history; 9 in non-Florida residents Alachua: 1 Brevard: 1 Broward: 3 Collier: 1 Duval: 1 Hillsborough: 1 Lake: 1 Marion: 2 Miami-Dade: 4 Nassau: 2 Orange: 3 Palm Beach: 3 Polk: 2 St. Lucie: 2 Volusia: 1 What mosquito-borne diseases are tracked in Florida? The Florida Department of Health tracks travel- and locally acquired cases of the followed mosquito-borne diseases: West Nile fever and West Nile encephalitis Eastern equine encephalitis virus St. Louis encephalitis virus Dengue virus Chikungunya virus Zika virus California encephalitis group viruses Malaria Florida has more than 80 types of mosquitoes. Here are 5 'most wanted' The Florida Department of Health said there are more than 80 different species of mosquitoes in Florida, compared to about 3,500 species in the world. While not all of them cause disease, here are five the agency lists as "Florida's most wanted": Aedes aegypti, the yellow fever mosquito Larvae are found in water-holding objects found around the home and yard, such as flower vases, tires, toys, bottles, conch shells, cans, refrigerator drain pans, barrels, bromeliad plants, and other containers. Can be found in all of Florida except Panhandle counties. Diseases: Dengue, chikungunya, and Zika viruses. Aedes albopictus, the Asian tiger mosquito Larvae found in water-holding objects found around the home and yard, such as flower vases, tires, toys, bottles, cans, barrels, tree holes, bromeliad plants, and other containers. Found in all Florida counties. Diseases: Dngue, chikungunya, and Zika viruses. Culex quinquefasciatus, southern house mosquito Larvae are found in a variety of aquatic habitats, especially those with high organic content, including catch basins, ditches, containers, dairy lagoons, and others. Found in all Florida counties and are abundant throughout the state. Diseases: Dog heartworm, St. Louis encephalitis virus, West Nile virus. Aedes taeniorhynchus, Black salt marsh mosquito Larvae are found in salt marshes. Found in all Florida counties and are strong fliers that are major pests during summer and early fall. Disease: Dog heartworm. Psorophora ciliata, Gallinipper Larvae are found in ditches, containers, grassy pools, furrows of citrus groves, pasture areas. Found in all Florida counties. Diseases: None none. What attracts mosquitoes? While there's not much we can do about some conditions mosquitoes are attracted to — this is Florida — we should note mosquitoes are drawn to: Damp or humid areas Standing water Warm temperatures Dark, shady areas Carbon dioxide (your breath) Myth or magic? Do mosquito-repelling plants really work? Mosquitoes need standing water to lay their eggs. And they don't need much. Water in a bottle cap can provide an ideal breeding ground. Experts repeatedly encourage residents to empty flower pots, bird baths and any outdoor item that holds standing water — including bromeliads — to stop mosquitoes from breeding. Some residents share ideas to make outdoor living more bearable by selecting mosquito-repelling plants for their landscape, especially citronella and lavendar. But do they really work? 'Certain plants do contain mosquito-repelling compounds,' says Liah Continentino, environmental horticulture agent with University of Florida/IFAS Extension Monroe County. 'But unless you're extracting their oils and applying them like a spray, they're not doing much just sitting in your garden. 'Plants like eucalyptus, citronella, mint, basil, lavender and marigolds have oils that can deter mosquitoes. But the key word is 'oils.' These compounds need to be extracted and used in concentrated forms — like sprays — to be truly effective." In other words, mosquito-repelling plants are more myth than magic — at least when it comes to passive protection, UF said in a news release. So what can Florida residents do to minimize mosquitoes? Don't give up when it comes to enjoy Florida outdoor living. There are some things you can do and some do involve plants. Here are a few ideas: Reduce mosquito habitats 'This includes regularly emptying plant saucers, bird baths, pet water bowls and bromeliads, as well as any other water-holding plants. Refreshing bird baths and pet bowls with clean water several times a week and flushing bromeliad cups with a hose can help prevent larvae from developing,' said Jennifer Pelham, UF/IFAS urban horticulture agent and director of UF/IFAS Extension Martin County. Use plants in your landscape to attract mosquito predators "For dragonflies, which are highly effective mosquito hunters, they are drawn to native aquatic plants. For birds, include shrubs and trees that supply food, shelter and nesting areas,' said Lorna Bravo, urban horticulture agent with UF/IFAS Extension Broward County. Use fish to control larvae For water features that are permanent, such as ornamental ponds, UF/IFAS recommends adding mosquito-eating fish like Gambusia to naturally control larvae. Cover rain barrels with screens and refresh pet water bowls daily to prevent mosquito access. Encourage mosquito predators in your yard, including fish, dragonflies, fronts, birds and bats. What are the best mosquito repellents to use? According to the CDC, repellents with the following active ingredients "typically provide reasonably long-lasting protection": DEET Picaridin Oil of Lemon Eucalyptus or PMD "Products containing oil of lemon eucalyptus specifies that they should not to be used on children under the age of 3." IR3535 2-undecanone "Certain products containing permethrin are recommended for use on clothing, shoes, bed nets, and camping gear, and are registered with EPA for this use." Items that don't work to repel mosquitoes "There are many gimmicks for sale that do not work, so be an educated consumer and don't waste your money on impulse buys," the Florida Department of Health said. Some items that are not effective for reducing mosquitoes include: Mosquito plants Bug zappers Consumption of garlic, vitamin B, and bananas Repellent bracelets and wristbands Ultrasonic devices and cell phone apps Dragonfly mimics This article originally appeared on Florida Today: World's deadliest animal are mosquitos. 80 types in Florida Solve the daily Crossword
Yahoo
3 days ago
- Yahoo
Boehringer's Hernexeos receives fast-tracked FDA approval
Boehringer Ingelheim has received fast-track approval from the US Food and Drug Administration (FDA) for its targeted therapy, Hernexeos (zongertinib tablets), to treat non-small cell lung cancer (NSCLC). This approval succeeds the positive results of the Phase Ib Beamion-LUNG 1 trial (NCT04886804), with the oral tyrosine kinase inhibitor (TKI) demonstrating an objective response rate (ORR) of 75% in patients with HER2-positive NSCLC who had received prior lines of platinum-based chemotherapy. Its FDA approval makes it the first oral treatment for HER2-positive NSCLC. Hernexeos also triggered a duration of response (DOR) of more than six months in 58% of the 71 patients previously treated with chemotherapy alone, while 27% of the 34 individuals with prior exposure to chemotherapy and a HER2 targeted therapy experienced a DOR of this length. Impacting 2%-4% of patients diagnosed with NSCLC, HER2 mutations are associated with poor prognosis and a higher risk of brain metastasis, while treatment options are highly limited in this population. Due to Hernexeos' potential to fulfil unmet needs in this indication, the FDA granted Boehringer priority review and breakthrough therapy designation last year. The therapy's full approval will likely rely on verification of clinical benefit in a confirmatory trial. Dr John Heymach, co-ordinating investigator on the Beamion-LUNG 1 trial and chair of thoracic/head and neck medical oncology at the MD Anderson Cancer Centre, said: 'The approval of zongertinib offers an effective and targeted treatment option for patients with HER2-mutant NSCLC in the US that not only elicits a durable response, but also has a manageable safety profile. 'In a patient population where there are currently limited treatment options, this approval represents a significant advancement in cancer care.' HER2-targeted therapy race heats up Though the current standard of care (SoC) for patients with HER2-mutated NSCLC still revolves around a platinum-based chemotherapy regimen, physicians are increasingly prescribing targeted therapies to improve outcomes. A notable example of this is AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan), which became the first HER2-targeting therapy to receive approval for NSCLC in 2022. Following its accelerated FDA approval, the drug has already reached blockbuster status – raking in $4.1bn in 2024 for the company, according to Pharmaceutical Technology's parent company, GlobalData. GlobalData predicts that the drug is on track to pull in $14.6bn by 2031, highlighting the lucrative nature of the targeted oncology market. However, Hernexeos has demonstrated a higher ORR of 75% compared with Enhertu's 56% in the DESTINY-Lung02 trial. The TKI has also proved efficacious in patients who had previously received treatment with an ADC, suggesting that the TKI could absorb some of Enhertu's market share. Looking ahead, the drug may also face competition from other targeted therapies currently in Phase III clinical trials, with GlobalData giving Bayer's TKI sevabertinib a likelihood of approval (LoA) score of 81% in this indication. "Boehringer's Hernexeos receives fast-tracked FDA approval" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
4 days ago
- Business Upturn
Shilpa Medicare shares jump 3% after CDSCO approval for NorUDCA tablets
By Aman Shukla Published on August 11, 2025, 09:19 IST Shilpa Medicare Limited shares surged by 3% in morning trade following a major announcement from the company. As of 9:18 AM, the shares were trading 3.83% higher at Rs 863.85. The Central Drugs Standard Control Organization (CDSCO) has granted approval for Shilpa Medicare's Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, indicated for the treatment of Non-alcoholic Fatty Liver Disease (NAFLD). This approval is a significant milestone as it marks the first global authorization of NorUDCA for NAFLD treatment. NAFLD is a widespread liver condition, affecting approximately 25% of the global population, which translates to nearly 1.2 billion people worldwide. In India alone, around 188 million people are estimated to suffer from NAFLD. If left untreated, NAFLD can advance to non-alcoholic steatohepatitis (NASH), causing severe liver damage and complications. NorUDCA is recognized for its choleretic and anti-inflammatory effects, which help improve bile flow, reduce liver inflammation, and potentially slow the progression of liver diseases related to NAFLD. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
